Tirzepatide in California got harder to get through Medi-Cal and cheaper to buy with cash in 2026. On January 1, 2026, Medi-Cal stopped covering Zepbound and Wegovy for adult weight loss. In April, the FDA moved to shut down compounded copies of the brand-name drugs for good. What’s left is the brand-name pen, bought with cash at the manufacturer’s price.
Zepbound runs $299 to $449 a month by dose, Wegovy $349. You’ll still need a prescription from a physician licensed in California.
If you lost coverage in January or a clinic quoted you something very different, this is for you.
TL;DR: Key Takeaways
- Tirzepatide is prescription-only. You qualify if your BMI is 30, or 27 along with a weight-related condition.
- Since 2025, compounding copies of both drugs has been off-limits. On April 30, 2026, the FDA proposed making that permanent.
- Medi-Cal no longer covers GLP-1s for adult weight loss. It still covers them for diabetes and for members under 21.
- Cash prices as of October 21, 2026: Zepbound runs $299 to $449 by dose, Wegovy $349 at every dose.
- August AI’s $39 visit is for brand-name prescriptions sent to your California pharmacy. No compounded product.
Want to know if Zepbound or Wegovy is right for you? Book a $39 visit with August AI. A board-certified MD reviews your BMI and health history and, when clinically appropriate, sends a prescription to the California pharmacy you choose. The visit does not guarantee a prescription, August does not prescribe compounded GLP-1s, and medication costs are separate. Severe stomach pain, vomiting that won’t stop, or a lump in your neck need in-person care, not an online visit.
Tirzepatide, Semaglutide, Ozempic, and Wegovy in California: Which Is Which?
The label matters, because Medi-Cal now pays for one and not the other. Tirzepatide is the active ingredient in two different injectable medicines. Mounjaro is approved for type 2 diabetes. Zepbound is the same drug approved for chronic weight management and for obstructive sleep apnea in adults with obesity.
Semaglutide works the same way: Ozempic treats type 2 diabetes and lowers heart and kidney risk in people who have it, while Wegovy is approved for weight management and for lowering heart risk in adults with obesity and heart disease. Foundayo and the Wegovy pill are the tablet options.
A pharmacy can’t substitute Mounjaro for Zepbound just because both contain tirzepatide. If you’re paying out of pocket, compare prices for your prescribed dose, not the starting dose.
Compounded Tirzepatide and Semaglutide in California: What’s Still Legal
Compounding pharmacies could make copies while the drugs were on the FDA’s shortage list. Tirzepatide came off in December 2024, semaglutide in February 2025, and by mid-2025 copies were off-limits for compounding pharmacies and 503B facilities alike.
On April 30, 2026, the FDA proposed removing both drugs from the list of substances 503B facilities can compound from bulk ingredients, under any circumstances. For regular pharmacies, the exceptions are narrow: a documented allergy to an ingredient in the brand-name drug, or a strength that isn’t commercially available.
California follows the federal rules, and several of the telehealth companies that sold compounded semaglutide are based here. If a California clinic or website still offers compounded tirzepatide or compounded semaglutide, ask which pharmacy makes it, why the brand-name version isn’t suitable for you, and whether the product is FDA-approved. Compounded versions are not.
Ozempic and Semaglutide Injections in California: What They Cost
These are the manufacturers’ cash prices as of October 21, 2026. Check LillyDirect or NovoCare the day you order. Prescription drugs are exempt from California sales tax, so the cash price is the price.
| Medication | How you get it in California | Monthly cost without insurance | Notes |
|---|---|---|---|
| Zepbound (tirzepatide) | Prescription; vials through LillyDirect | $299 at 2.5 mg (a starting dose only), $399 at 5 mg, $449 at 7.5 mg and up | The $449 holds only if you refill within 45 days; late refills at higher doses jump to $499 to $699 |
| Mounjaro (tirzepatide) | Prescription; diabetes label, LillyDirect self-pay | Same tiers as Zepbound | Same 45-day rule; Medi-Cal still covers it for diabetes |
| Wegovy pen (semaglutide) | Prescription; NovoCare or Novo’s savings card at most pharmacies | $349 at every dose; $199 for the first two fills at the two lowest doses | List price about $1,349 without the program |
| Wegovy pill (semaglutide) | Prescription; NovoCare | $149 starter dose, $199 to $299 at higher doses | A daily tablet |
| Ozempic pen (semaglutide) | Prescription; diabetes label | $349 for 0.25 to 1 mg; $499 for 2 mg | Medi-Cal still covers it for diabetes |
| Compounded tirzepatide or semaglutide | Not legal to compound as a copy since 2025 | $99 to $399 where still sold | Not FDA-approved |
| August AI visit | Online, 24/7 | $39 for the MD consult | Medication billed separately |
Two things stand out. For semaglutide injections in California, Wegovy’s $349 monthly price is about a quarter of its list price, so the brand now costs about what compounded did. For Ozempic injections in California, Medi-Cal still covers the drug for patients with diabetes, but not for weight loss alone.
Watch the Zepbound refill deadline: refill on day 46 instead of day 45, and the same 10 mg box costs $699 instead of $449. To estimate a year of treatment at your prescribed dose, use the GLP-1 budget calculator.
Does Medi-Cal or Insurance Cover Tirzepatide in California?
Medi-Cal. Medi-Cal covered Zepbound and Wegovy for weight loss until December 31, 2025. For adults, it doesn’t anymore. The change is in the state budget law, SB 101, and our Medi-Cal guide covers what the program still pays for. Three exceptions: the drug is still covered if it’s medically necessary for something other than weight loss, such as diabetes; members under 21 are still covered for weight loss under federal rules; and if you’re denied, you have 90 days to request a State Hearing. If you were already on the drug and ask within 10 days of the denial, Medi-Cal keeps covering it until the hearing is decided.
Employer and Covered California plans. Plan by plan. Most cover Mounjaro and Ozempic for diabetes with prior authorization; Zepbound or Wegovy for weight alone is the exception. Run yours through August’s GLP-1 coverage check before you pay cash.
Medicare. Since July 1, 2026, Medicare’s GLP-1 Bridge Program covers Wegovy, Zepbound, and Foundayo for weight loss at a $50 monthly copay, with prior authorization. You qualify with a BMI of 35; or 30 with heart failure, hard-to-control high blood pressure, or stage 3a or worse kidney disease; or 27 with prediabetes, a prior heart attack or stroke, or peripheral artery disease. It runs through 2027.
What a Legal GLP-1 Consult in California Looks Like
California requires a real medical evaluation before a clinician prescribes weight-loss medication. Under Business and Professions Code section 2242, a prescription needs a medical reason and a prior examination that meets the standard of care.
The exam can happen by telehealth. A physician, nurse practitioner, or physician assistant has to do it; a nurse or aesthetician can’t prescribe these medications on their own. A questionnaire alone doesn’t count. The clinician has to assess you and write a plan for you, not a standing order.
So if your “consult” at a clinic was a form and a brief chat with a nurse, it didn’t meet California’s rule. A telehealth visit where a licensed clinician reviews your history, decides whether the medication is right for you, and writes your plan is what the law describes.
How to Get Tirzepatide Online in California
California lets a physician prescribe by telehealth without a prior in-person visit, as long as the evaluation meets the standard of care. The visit works like this:
- Health history. Weight, height, conditions, medications, family history of thyroid cancer. August reviews this part for free.
- The MD chat. $39. The doctor checks whether your BMI clears the threshold (30, or 27 with a weight-related condition) and talks through Zepbound, Wegovy, Foundayo, and Contrave.
- The prescription. If you qualify, it goes to the California pharmacy you choose.
- Labs, if needed. An A1C, lipids, or a metabolic panel through August’s lab tests, drawn locally.
- Follow-up. Side effects and dose changes, by message.
Side Effects and Who Shouldn’t Take It
Nausea and constipation are common, worst in the week or two after a dose increase, and ease as your body adjusts. Severe or ongoing stomach pain, vomiting that won’t stop, or a new lump in your neck are different: stop and get seen in person.
Don’t use tirzepatide if you’re pregnant or planning on getting pregnant. It’s also not recommended if you or a family member has had medullary thyroid cancer, or if you have multiple endocrine neoplasia syndrome type 2 (MEN2). The tirzepatide page covers the full list of risks and precautions.
Conclusion
Getting tirzepatide in California in 2026 comes down to three things: Medi-Cal no longer covers Zepbound for adult weight loss, the FDA has proposed closing the last door on compounded copies, and brand-name Zepbound costs $299 to $449 a month, by dose. Get evaluated by a clinician licensed in California, choose a pharmacy you trust, and confirm the price the day you fill it. When you’re ready, book a $39 visit.
Frequently Asked Questions
Not as a cheaper copy of Zepbound or Mounjaro. Since the shortage ended, a pharmacy can compound it only when a clinician documents a reason the brand won’t work for you.
Not for adult weight loss, since January 1, 2026. Still covered for diabetes and other medically necessary uses, and for members under 21. If you’re denied, you have 90 days to request a State Hearing.
A clinician can prescribe Ozempic off-label for weight loss, but insurers almost never cover it for that, and Medi-Cal covers it for type 2 diabetes only. Ask about Wegovy instead; it’s approved for weight and costs the same $349 cash.
